C07C 271/30
To a carbon atom of a six-membered aromatic ring being part of
Official title: to a carbon atom of a six-membered aromatic ring being part of a condensed ring system
C07C271/30 (To a carbon atom of a six-membered aromatic ring being part of) appears on 41 US grants and 46 published applications in this corpus.
Search patents in C07C- Granted patents
- 41
- Published applications
- 46
- Assignees
- 34
- Inventors
- 177
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 2 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 5 | 1 |
| 2002 | 2 | 3 |
| 2003 | 2 | 5 |
| 2004 | 2 | 4 |
| 2005 | 2 | 0 |
| 2006 | 2 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 1 |
| 2009 | 0 | 2 |
| 2010 | 1 | 2 |
| 2011 | 3 | 3 |
| 2012 | 2 | 4 |
| 2013 | 1 | 3 |
| 2014 | 3 | 1 |
| 2015 | 2 | 3 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 1 |
| 2019 | 2 | 3 |
| 2020 | 1 | 3 |
| 2021 | 1 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 1 |
| 2024 | 0 | 0 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Aug 2026US 12,698,255 B2ImmuneBridge Inc.
- Selective inhibitors of NLRP3 inflammasome11 Mar 2025US 12,247,011 B2NodThera Limited
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene4 Oct 2022US 11,459,293 B2ImmuneBridge Inc.
- Benzene fused heterocyclic derivative and pharmaceutical composition comprising the same17 Aug 2021US 11,091,421 B2Taiwanj Pharmaceuticals Co., Ltd.
- Naphthoquinones, pro-drugs, and methods of use thereof10 Nov 2020US 10,829,427 B2Board of Regents, The University of Texas System
- Selective inhibitors of nlrp3 inflammasome10 Jul 2025US 2025/0223263 A1NodThera Limited
- Anti-inflammatory and analgesic compounds and use thereof24 Apr 2025US 2025/0129012 A1Jiangsu Atom Bioscience and Pharmaceutical Co., Ltd.
- Compositions and methods of making expanded hematopoietic stem cells using derivatives of fluorene13 Apr 2023US 2023/0112489 A1ImmuneBridge Inc.
- Selective inhibitors of nlrp3 inflammasome25 Mar 2021US 2021/0087147 A1NodThera Limited
- Fluorene compound and pharmaceutical use thereof1 Oct 2020US 2020/0308109 A1Japan Tobacco Inc.
Most cited
By later US patents
- 9-substituted minocycline compounds83US 6,846,939 B2Paratek Pharmaceuticals, Inc. · 2005
- Compositions and methods of the use thereof achiral analogues of CC-1065 and the duocarmycins81US 6,660,742 B2Taiho Pharmaceutical Co., Ltd. · 2003
- 7-and 9-carbamate, urea, thiourea, thiocarbamate, and heteroaryl-amino substituted tetracycline compounds79US 6,818,634 B2Paratek Pharmaceuticals, Inc. · 2004
- 13-substituted methacycline compounds59US 6,500,812 B2Paratek Pharmaceuticals, Inc. · 2002
- Urokinase inhibitors52US 6,258,822 B1Abbott Laboratories · 2001